Financial Results

Organigram Posts Stellar Q3 2018 Results

Organigram Holdings released third-quarter financial results for the period that ended on May 31st, 2018.Growth in production, dried flower sales, oil sales, inventory and the anno...

Elixinol crush Q2 sales…but is there more?

Elixinol Global Sales Rise 111% in Q2 to A$8 MillionAustralian hemp company Elixinol Global shared Q2 financial results in a press release issued on July 30th, with sales of A$8.0 ...

Aphria Shout Revenue Growth but Expenses Disappoint.

Aphria released fourth quarter financial results for the period that ended on May 31stKey Financial Highlights During the quarter, Aphria reported an approx. $5 million net loss o...

CV Sciences Crush Their 2018 Financial Results

CV Sciences reported second quarter 2018 financial results.Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 Million."C...

MPX Continues to Impress with Their 2018 Results

MPX Bioceutical Corporation reported its Full Year 2018 financial results.Following the acquisition of its first two dispensaries in Arizona, which operate under the Health for Lif...

GW Pharmaceuticals releases Q3 results

Q3 financial results - Operational HighlightsGW Pharmaceuticals (GWPH) released third quarter financial results for the period that ended on June 30th.Epidiolex (cannabidiol)Regula...

Record Revenue for Q2 2018

CannTrust Holdings Inc. ("CannTrust" or the "Company" | TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulati...

2018 Q2 results – Making Strong Progress

The Green Organic Dutchman Holdings Ltd. ("TGOD") (TSX: TGOD) (US: TGODF) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 201...

$1.5 million in revenue in 2018 Q2

Revenues increased 180% over the quarter ended June 30, 2017 and 18% over Q1 2018Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) ("Emblem" or the "Company"), a licensed producer of medical ...

iAnthus 2018 Q2 sales Growth of Over 40%

iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United St...